New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

BACKGROUND: Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of more...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Youki, Takeda, Midori, Mori, Kyoko, Dansako, Hiromichi, Wakita, Takaji, Kim, Hye-Sook, Sato, Akira, Wataya, Yusuke, Ikeda, Masanori, Kato, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758303/
https://www.ncbi.nlm.nih.gov/pubmed/24023620
http://dx.doi.org/10.1371/journal.pone.0072519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758303/
https://www.ncbi.nlm.nih.gov/pubmed/24023620
http://dx.doi.org/10.1371/journal.pone.0072519

Ejemplares similares